Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative RARE - Ultragenyx Pharmaceutical Inc.
322 M
LAST VALUE
7.53%
2 YEAR CAGR
14.77%
5 YEAR CAGR
40.39%
10 YEAR CAGR